已核实 DOI PubMed 相关产品: 95

Engineering Hibiscus-Like Riboflavin/ZIF-8 Microsphere Composites to Enhance Transepithelial Corneal Cross-Linking

Journal 2022 · IF 32.086 · 34(21): 2109865 · 发表于 2022 年 3 月 22 日
作者: Mei Yang,Wenjin Xu,Zhongxing Chen,Ming Chen,Xiaoyu Zhang,Huanhuan He,Yushan Wu,Xueyang Chen,Tianjiao Zhang,Mengdi Yan,Jieyi Bai,Colm McAlinden,Keith M. Meek,Jinjin Yu,Shengnan Ding,Rongrong Gao,Jinhai Huang,Xingtao Zhou
阅读全文 在 PubMed 查看

摘要

Riboflavin-5-phosphate (RF) is the most commonly used photosensitizer in corneal cross-linking (CXL), but its hydrophilicity and negative charge limit its penetration through the corneal epithelium into the stroma. To enhance the corneal permeability of RF and promote its efficacy in the treatment of keratoconus, novel hibiscus-like RF@ZIF-8 microsphere composites [6RF@ZIF-8 NF (nanoflake)] are prepared using ZIF-8 nanomaterials as carriers, which are characterized by their hydrophobicity, positive potential, biocompatibility, high loading capacities, and large surface areas. Both hematoxylin and eosin endothelial staining and TUNEL assays demonstrate excellent biocompatibility of 6RF@ZIF-8 NF. In in vivo studies, the 6RF@ZIF-8 NF displayed excellent corneal permeation, and outstanding transepithelial CXL (TE-CXL) efficacy, slightly better than the conventional CXL protocol. Furthermore, the special hibiscus-like structures of 6RF@ZIF-8 NF meant that it has better TE-CXL efficacy than that of 6RF@ZIF-8 NP (nanoparticles) due to the larger contact area with the epithelium and the shorter RF release passage. These results suggest that the 6RF@ZIF-8 NF are promising for transepithelial corneal cross-linking, avoiding the need for epithelial debridement.

本研究中使用的阿拉丁产品

95 款产品在本文中被引用